Next 10 |
2024-05-16 11:01:24 ET Billionaire Larry Robbins' Glenview Capital Management took a stake in Broadcom ( NASDAQ: AVGO ), exited its position in Intel ( NASDAQ: INTC ), and substantially added to holdings in health insurers in Q1 2024, among other changes.... Read the f...
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Matthew Shields as Executive Vice President of Teva Global Operations (TGO), the Company’s manufacturing and supply division, effective June 3, 2024. Mr. Shields succeeds Eric Drapé, who is le...
2024-05-14 14:35:08 ET Teva Pharmaceutical Industries Limited (TEVA) BofA Securities 2024 Health Care Conference May 14, 2024, 11:40 AM ET Company Participants Jason Gerberry - Managing Director, US Specialty Pharma and Smid Cap Biotech Richard Francis - President &a...
2024-05-09 08:15:00 ET Summary Teva Pharmaceutical stock has been trending higher since October 2023, closing at nearly $16.00. The company reported strong first-quarter results, with increased revenue and growth in key metrics. Teva has a positive business outlook for 2024, w...
2024-05-09 02:19:50 ET Summary Teva's Q1 earnings show continued momentum, with a 5% increase in total revenue and a jump in gross profit. The Company's blockbuster drugs, Austedo and Ajovy, continue to show robust growth and contribute to the company's revenue. TEVA's current...
2024-05-08 14:00:14 ET Image source: The Motley Fool. Teva Pharmaceutical Industries (NYSE: TEVA) Q1 2024 Earnings Call May 08, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Teva Pharmaceutical Industries (TEVA) Q1 202...
2024-05-08 11:32:14 ET Teva Pharmaceutical Industries Limited (TEVA) Q1 2024 Earnings Conference Call May 08, 2024, 08:00 AM ET Company Participants Ran Meir - Head, Investor Relations Richard Francis - Chief Executive Officer Eric Hughes - Head, R&D & Ch...
2024-05-08 10:13:13 ET More on Teva Pharmaceutical Teva Pharmaceutical Industries Limited 2024 Q1 - Results - Earnings Call Presentation Teva Pharmaceutical Industries: Potential Outweighs Concerns Teva And Alvotech: Simlandi Approval Opens New Generic Market Opportu...
2024-05-08 07:40:43 ET More on Teva Pharmaceutical Teva Pharmaceutical Industries: Potential Outweighs Concerns Teva And Alvotech: Simlandi Approval Opens New Generic Market Opportunities Teva Pharmaceutical: I Need To See Top-Line Growth Return Before Starting A Pos...
2024-05-08 07:03:09 ET More on Teva Pharmaceutical Teva Pharmaceutical Industries: Potential Outweighs Concerns Teva And Alvotech: Simlandi Approval Opens New Generic Market Opportunities Teva Pharmaceutical: I Need To See Top-Line Growth Return Before Starting A Pos...
News, Short Squeeze, Breakout and More Instantly...
Teva Pharmaceutical Industries Limited American Depositary Shares Company Name:
TEVA Stock Symbol:
NYSE Market:
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA)...
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Matthew Shields as Executive Vice President of Teva Global Operations (TGO), the Company’s manufacturing and supply division, effective June 3, 2024. Mr. Shields succeeds Eric Drapé, who is le...
These large-cap stocks were the best performers in the last week. Are they in your portfolio? Teva Pharmaceutical Industries (NYSE:TEVA) shares s...